Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nyingi Kemmer

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Gastroenterology & Hepatology|August 23, 2011
Ethnic disparities in liver transplantationNyingi Kemmer
Digestive Diseases and Sciences|October 16, 2007
Ethnic variations in chronic liver diseasesNyingi Kemmer, Guy W Neff
Digestive Diseases and Sciences|April 25, 2009
Liver transplantation in the ethnic minority population: challenges and prospectsNyingi Kemmer, Guy W Neff
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2007
Managing chronic hepatitis C in the difficult-to-treat patientNyingi Kemmer, Guy W Neff
Case Reports in Gastroenterology|November 10, 2010
Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and VancomycinGeorge Tannous, Guy Neff, Nyingi Kemmer
Therapeutic Advances in Gastroenterology|December 25, 2010
Predicting the probable outcome of treatment in HCV patientsUdayakumar Navaneethan, Nyingi Kemmer, Guy W Neff
Hepatology (Baltimore, Md.)|June 27, 2006
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequencesJason T Blackard, Nyingi Kemmer, Kenneth E Sherman
Narrative Inquiry in Bioethics|April 30, 2019
Malleable Transplant Criteria: At What Cost?Angel Alsina, Rebekah Apple, Nyingi Kemmer, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 30, 2013
Update on the management of cirrhosis - focus on cost-effective preventative strategiesGuy W Neff, Nyingi Kemmer, Christopher Duncan, et al.
Digestive Diseases and Sciences|December 4, 2008
Access to liver transplantation in the MELD era: role of ethnicity and insuranceNyingi Kemmer, Victoria Zacharias, Tiffany E Kaiser, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Gastroenterology & Hepatology|August 23, 2011
Ethnic disparities in liver transplantationNyingi Kemmer
Digestive Diseases and Sciences|October 16, 2007
Ethnic variations in chronic liver diseasesNyingi Kemmer, Guy W Neff
Digestive Diseases and Sciences|April 25, 2009
Liver transplantation in the ethnic minority population: challenges and prospectsNyingi Kemmer, Guy W Neff
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2007
Managing chronic hepatitis C in the difficult-to-treat patientNyingi Kemmer, Guy W Neff
Case Reports in Gastroenterology|November 10, 2010
Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and VancomycinGeorge Tannous, Guy Neff, Nyingi Kemmer
Therapeutic Advances in Gastroenterology|December 25, 2010
Predicting the probable outcome of treatment in HCV patientsUdayakumar Navaneethan, Nyingi Kemmer, Guy W Neff
Hepatology (Baltimore, Md.)|June 27, 2006
Extrahepatic replication of HCV: insights into clinical manifestations and biological consequencesJason T Blackard, Nyingi Kemmer, Kenneth E Sherman
Narrative Inquiry in Bioethics|April 30, 2019
Malleable Transplant Criteria: At What Cost?Angel Alsina, Rebekah Apple, Nyingi Kemmer, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 30, 2013
Update on the management of cirrhosis - focus on cost-effective preventative strategiesGuy W Neff, Nyingi Kemmer, Christopher Duncan, et al.
Digestive Diseases and Sciences|December 4, 2008
Access to liver transplantation in the MELD era: role of ethnicity and insuranceNyingi Kemmer, Victoria Zacharias, Tiffany E Kaiser, et al.
Pageof 4